AdvaMed’s Top 10 Medtech Wins in 2022
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel companies, 2022 was a…
Learn more about our Health Equity work.
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel companies, 2022 was a…
October is Breast Cancer Awareness Month and a good time to remember the importance of diagnostic screenings in saving lives.
AdvaMed submitted a letter to CMS’s RFI on Medicare regarding ways to strengthen the Medicare Advantage program to align with the Vision for Medicare and CMS’ Strategic Pillars.
The Advanced Medical Technology Association, AdvaMed, today welcomed several outcomes of the just-concluded IX Summit of the Americas in Los Angeles.
The Advanced Medical Technology Association (AdvaMed) released a report titled “Approaches to Increasing Diversity in Clinical Research and Addressing Health Inequities”, a new document intended to outline considerations and approaches…
This document is intended to outline some of the potential considerations and possible approaches to help research sponsors improve inclusion of under-represented groups in clinical research.
Based on insights from a related workshop series, this document outlines potential considerations and possible approaches to help research sponsors improve inclusion of under-represented groups in clinical research.
For National Minority Cancer Awareness Month, AdvaMed’s DeChane Dorsey reflects on the continued need for improvements in health equity and the impact of cancer on racial and ethnic minority groups.
AdvaMed submitted a response to a White House Office of Science and Technology Policy (OSTP) Request for Information (RFI) on Strengthening Community Health Through Technology.